Table 1 Baseline patients characteristic
ALL HTX RECIPIENTS | WITH HEMODYNAMIC INSTABILITY | WITHOUT HEMODYNAMIC INSTABILITY | p-value | |
|---|---|---|---|---|
n = 45 | n = 18 | n = 27 | ||
Demography | ||||
Sex | 1.000 | |||
Female | 4 (8.89) | 2 (11.1) | 2 (7.41) | |
Male | 41 (91.1) | 16 (88.9) | 25 (92.6) | |
Age, years | 48.5 (11.7) | 51.2 (12.0) | 46.7 (11.5) | 0.215 |
BMI, kg/m2 | 25.6 (4.11) | 27.9 (3.61) | 24.3 (3.83) | 0.009 |
Hiperlipidemia | 15 (33.3) | 6 (33.3) | 9 (33.3) | 1.000 |
Diabetes | 11 (24.4) | 7 (38.9) | 4 (14.8) | 0.086 |
Cardiomyopathy | 0.732 | |||
Dilated | 34 (75.6) | 13 (72.2) | 21 (77.8) | |
Ischemic | 11 (24.4) | 5 (27.8) | 6 (22.2) | |
Preoperative parameters | ||||
Urgent HTX | 36 (80.0) | 13 (72.2) | 23 (85.2) | 0.449 |
iv DBa | 33 (73.3) | 11 (61.1) | 22 (81.5) | 0.175 |
iv inotropic agentsb | 11 (24.4) | 6 (33.3) | 5 (18.5) | 0.304 |
AST, U/L | 29.0 (22.3) | 23.6 (9.96) | 32.4 (27.1) | 0.132 |
ALT, U/L | 32.1 (33.3) | 27.2 (20.1) | 35.2 (39.6) | 0.382 |
TBIL, μmol/L | 13.2 (8.86) | 12.8 (7.59) | 13.4 (9.75) | 0.833 |
CREA, μmol/L | 97.7 (29.1) | 114 (32.1) | 87.1 (21.4) | 0.005 |
GFR, mL/min/1.73m2 | 77.7 (20.5) | 65.6 (18.3) | 85.8 (17.9) | 0.001 |